References
Fleischmann RM, Schechtman J, Bennett R, et al. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: a large, international, multicenter, placebo-controlled trial. Arthritis Rheum 2003; 48: 927–34.
Furst DE. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. Clin Ther 2004; 26: 1960–75.
Nosbaum A, Pralong P, Rozières A, Dargaud Y, Nicolas JF, Bérard F. Delayed-type hypersensitivity to heparin: diagnosis and therapeutic management. Ann Dermatol Venereol 2012; 139: 363–8.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Lungoci, E.R., Hacard, F., Nicolas, JF. et al. Anakinra delayed skin allergy expressing as both injection site reactions and generalized exanthema. Eur J Dermatol 25, 503–504 (2015). https://doi.org/10.1684/ejd.2015.2624
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2015.2624